Ambrx Biopharma Cayman, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2020 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Ambrx Biopharma Cayman, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2020 to Q2 2023.
  • Ambrx Biopharma Cayman, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2023 was $357K, a 23.4% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $357K -$109K -23.4% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $380K Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $339K -$191K -36% Dec 31, 2022 10-Q 2023-08-09
Q2 2022 $466K Jun 30, 2022 6-K 2022-08-29
Q4 2021 $530K -$94K -15.1% Dec 31, 2021 10-K 2023-03-30
Q4 2020 $624K Dec 31, 2020 20-F 2022-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.